SUZHOU, China, Dec. 26, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a phase I/II clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous co ...

The Company's lead product, a unique once-daily formulation of tramadol, is being commercially launched in key markets globally. The Company also has a robust pipeline of follow-on products in both ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration subcutaneous co-formulation consisting of HER2 ...

Event Overview: Formulation Development is a key element in the pharmaceutical development process. There is an increasing trend by companies to outsource not just this service, but an integrated ...

Based on formulation simplicity and blinding capability, hard gelatin capsules are preferrable compared with other oral solid dosage forms, including tablets, in the early clinical phases of drug ...

As efforts to develop an effective vaccine for COVID-19 continue, in parallel, drug developers are investigating the effectiveness of existing drugs at treating patients with COVID-19. The ...

Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...

The oral probiotic supplement industry is experiencing a fundamental transformation in 2025, as consumers increasingly demand ingredient transparency and clinical research backing over marketing ...